Cannabis Strategic Ventures (NUGS)
0.00
USD |
OTCM |
Apr 25, 16:00
Cannabis Strategic Ventures Cash from Financing (TTM): 9.478M for June 30, 2020
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2020 | 9.478M |
March 31, 2020 | 11.46M |
December 31, 2019 | 9.726M |
September 30, 2019 | 7.521M |
June 30, 2019 | 5.622M |
March 31, 2019 | 2.347M |
December 31, 2018 | 1.791M |
Date | Value |
---|---|
September 30, 2018 | 1.76M |
June 30, 2018 | 0.8795M |
March 31, 2018 | 1.298M |
December 31, 2017 | 0.8046M |
September 30, 2017 | 0.7374M |
June 30, 2017 | 0.4657M |
March 31, 2017 | 0.017M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
5.622M
Minimum
Jun 2019
11.46M
Maximum
Mar 2020
8.761M
Average
9.478M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |